Lu Timothy K
Transaction: 03/09/2026
SELL
Change
-80,666
Price
Not reported
Filing
03/11/2026
Type
SELL
Senti Biosciences, Inc.
SNTI • Biotechnology
$0.33
▼ -0.01 (-2.49%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$10.36M
Growth
-65.9%
Cash Flow
0/5
Trend
Negative
Evidence
Healthy liquidity · 1.67High debt level · 5.17Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 21, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.33
Change-2.49%
Shares Out31.14M
Market Cap$10.36M
Enterprise Value$24.12M
52W Range0.33 - 2.88
Beta2.05
P/E-0.21
P/S272.60
P/B-3.05
P/FCF-0.27
EV/Sales634.78
Price$0.33
Change-2.49%
Shares Out31.14M
Market Cap$10.36M
Enterprise Value$24.12M
52W Range0.33 - 2.88
Beta2.05
P/E-0.21
P/S272.60
P/B-3.05
P/FCF-0.27
EV/Sales634.78
EV/EBITDA-0.44
EV/FCF-0.63
Earnings Yield-478.47%
FCF Yield-367.33%
Dividend Yield0.00%
Gross Margin-164.32%
Oper. Margin-2896.68%
Profit Margin-2792.64%
Debt/Eq5.17
Current Ratio1.67
Quick Ratio1.67
Revenue 5Y-65.93%
Target$6.00
Target Upside1703.97%
Target Median$6.00
Target Range6.00 - 6.00
Volume96.39K
Avg Volume246.40K
EPS Surprise-0.09
Investment DNA
How strong this company looks for long-term investors
26
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
55/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Healthy liquidity · 1.67High debt level · 5.17Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
75/100
Bullish
Bullish
2
Hold
2
Bearish
0
Price Target
2026-08-21
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
Rajangam Kanya
Transaction: 03/09/2026
SELL
Change
-10,757
Price
Not reported
Filing
03/11/2026
Type
SELL
Lu Timothy K
Transaction: 02/02/2026
SELL
Change
-4,191
Price
Not reported
Filing
02/03/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lu Timothy K | SELL | -80,666 | Not reported | 03/09/2026 | 03/11/2026 |
| Rajangam Kanya | SELL | -10,757 | Not reported | 03/09/2026 | 03/11/2026 |
| Lu Timothy K | SELL | -4,191 | Not reported | 02/02/2026 | 02/03/2026 |
| Rajangam Kanya | SELL | -1,384 | Not reported | 02/02/2026 | 02/03/2026 |
| Baum Bryan Daniel | OTHER | 0 | Not reported | 07/18/2025 | 07/21/2025 |
| Baum Bryan Daniel | BUY | +43,900 | $1.95 | 07/18/2025 | 07/21/2025 |
| Mathers Edward T | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| Tang Donald F | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| COOPERSTONE BRENDA | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| Schulz Fran | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| Hsiung Feng | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| Collins James J. | BUY | +21,950 | $2.05 | 06/25/2025 | 06/27/2025 |
| Celadon Partners SPV 24 | SELL | -9,777 | Not reported | 03/10/2025 | 03/14/2025 |
| Celadon Partners SPV 24 | BUY | +9,777,000 | Not reported | 03/10/2025 | 03/14/2025 |
| Celadon Partners SPV 24 | OTHER | +9,777,000 | $2.25 | 03/06/2025 | 03/13/2025 |
| Celadon Partners SPV 24 | OTHER | +6,666,000 | $2.30 | 03/06/2025 | 03/13/2025 |
| BAYER HEALTHCARE LLC | SELL | -2,222 | Not reported | 03/10/2025 | 03/12/2025 |
| BAYER HEALTHCARE LLC | BUY | +2,222,000 | Not reported | 03/10/2025 | 03/12/2025 |
| New Enterprise Associates 15, L.P. | SELL | -3,333 | Not reported | 03/10/2025 | 03/12/2025 |
| New Enterprise Associates 15, L.P. | BUY | +3,333,000 | Not reported | 03/10/2025 | 03/12/2025 |